tradingkey.logo

RAPT Therapeutics Inc <RAPT.OQ> expected to post a loss of 13 cents a share - Earnings Preview

ReutersMay 5, 2025 2:06 PM
  • RAPT Therapeutics Inc RAPT.OQ RAPT.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for RAPT Therapeutics Inc is for a loss of 13 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."

  • The mean earnings estimate of analysts had risen by about 1.1% in the last three months. ​

  • Wall Street's median 12-month price target for RAPT Therapeutics Inc is $4.00​, above​ its last closing price of $0.97. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.31

-0.37

-1.14

Missed

-206.5

Sep. 30 2024

-0.57

-0.56

-0.47

Beat

16.7

Jun. 30 2024

-0.72

-0.72

-0.71

Beat

1.4​

Mar. 31 2024

-0.80

-0.81

-0.79

Beat

2.3

​​Dec. 31 2023

-0.86

-0.86

-0.80

Beat

6.8

Sep. 30 2023

-0.75

-0.75

-0.82

Missed

-8.9​

Jun. 30 2023

-0.79

-0.78

-0.66

Beat

15.6

Mar. 31 2023

-0.67

-0.68

-0.76

Missed

-11.8

This summary was machine generated May 5 at 14:06 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI